Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands

INTRODUCTION: To improve therapeutic decision making, it is crucial that information regarding adverse drug reactions reaches patients. It is not enough to disseminate such findings through regulatory and scientific channels; targeted efforts to reach patients are necessary. One possible avenue is t...

Descripción completa

Detalles Bibliográficos
Autores principales: Härmark, Linda, Weits, Gerda, Meijer, Rietje, Santoro, Federica, Norén, G. Niklas, van Hunsel, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395903/
https://www.ncbi.nlm.nih.gov/pubmed/32418193
http://dx.doi.org/10.1007/s40264-020-00932-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395903/
https://www.ncbi.nlm.nih.gov/pubmed/32418193
http://dx.doi.org/10.1007/s40264-020-00932-5

Ejemplares similares